Received May 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 92DJ3 | — |
An adult patient received a pediatric dose of Engerix-B; An adult patient received a pediatric dose of Engerix-B; An adult patient received a pediatric dose of Engerix-B that was expired; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a 57-year-old female patient who received HBV (Engerix B) (batch number 92DJ3, expiry date 03-MAY-2025) for prophylaxis. On 12-MAY-2025, the patient received Engerix B. On 12-MAY-2025, an unknown time after receiving Engerix B, the patient experienced adult use of a child product (Verbatim: An adult patient received a pediatric dose of Engerix-B), underdose (Verbatim: An adult patient received a pediatric dose of Engerix-B) and expired vaccine used (Verbatim: An adult patient received a pediatric dose of Engerix-B that was expired). The outcome of the adult use of a child product, underdose and expired vaccine used were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-MAY-2025 On 12th May 2025, a medical assistant called to report that they had administered a pediatric dose of Engerix-B to an adult female patient (57 years old), but it had expired on 3rd May 2025, which led to Adult use of a child product, Underdose and Expired vaccine used. The dose had been administered on 12th May 2025.